Collaborate Disseminate
The first results from an advanced trial testing mRNA technology against cancer reveal 44% of patients fared better than those on conventional treatments alone. The preliminary announcement from Moderna reveals Phase 3 trials for its personalized mRNA … Continue reading Impressive results from “game-changing” mRNA skin cancer vaccine trial
An incredible new study published in the journal Science demonstrates the potential for a single mRNA vaccine to provide protection from all 20 known influenza A and B virus subtypes. It’s hoped the vaccine, so far seen to be effective in preclinical a… Continue reading Landmark 20-strain mRNA flu vaccine looks to prevent future pandemics
The authors of a new study can’t say if this impacted the midterms, but say that it’s “plausible given just how stark the differences in vaccination rates have been, among Democrats and Republicans.” Continue reading Almost Twice as Many Republicans Died From COVID Before the Midterms Than Democrats
Even when someone is determined to beat their fentanyl addiction, there’s still a good chance they will relapse at some point, and start taking the opioid again. A new vaccine is designed to help get them back on track, by blocking fentanyl’s effect on… Continue reading Experimental fentanyl vaccine stops the drug from entering the brain
A new paper in the journal JAMA Oncology has reported the results of a decade-long Phase 1 human trial testing an experimental breast cancer vaccine. The novel treatment was found to be “very safe” and a larger Phase 2 trial is now underway testing eff… Continue reading Experimental breast cancer vaccine passes first human trials
An ounce of prevention is worth a pound of cure, so they say. Scientists have now demonstrated a new potential cancer vaccine that involves injections of dormant tumor cells to stimulate the immune system and help prevent the onset of cancer.Continue R… Continue reading Cancer vaccine using “zombie” cells shows promise in mouse tests
After decades of research a long-awaited vaccine against respiratory syncytial virus (RSV) may finally be here. Preliminary Phase 3 data has revealed maternal immunization with a new vaccine delivered extraordinary protection from severe disease in bab… Continue reading “Remarkable” results for new maternal RSV vaccine in Phase 3 trial
Compelling new research from the University of Oxford has homed in on a specific genetic variant that seems to play a significant role in how well people generate an immune response to COVID-19 vaccines and their chances of experiencing a breakthrough … Continue reading Unique study links specific gene variant to COVID vaccine efficacy
Over the last couple of months researchers tracking emerging SARS-CoV-2 variants have started noticing something strange. No one new variant has looked like taking over but instead a variety of different subvariants seemed to be accumulating the same m… Continue reading As Omicron mutates wildly the virus shows first signs of convergent evolution
The US Food and Drug Administration (FDA) has authorized new mRNA vaccine booster shots targeting the BA.4 and BA.5 Omicron variant of SARS-CoV-2. The authorization marks the first updated COVID-19 vaccines to be made available in the United States sin… Continue reading Omicron COVID vaccine booster authorized in US, roll-out begins in days